Senators heard a status report on the social equity task force, concerns from past and prospective applicants, and a rebuttal from WSLCB staff on licensing decision making.
During a panel on medical cannabis, Senate President Pro Tempore Karen Keiser announced previous legislation to make cannabis more affordable for medical patients would be reintroduced.
Legislators heard an update from WSLCB leadership on their COVID-19 response and seemed eager to support legislation to more permanently encode some temporary alcohol allowances.
State and local officials as well as cannabis industry stakeholders discussed the Social Equity in Cannabis Task Force, excise taxes on medical marijuana, and a cannabis research commission.
On Monday, legislators in both chambers planned to review social equity within the cannabis industry, medical marijuana, a proposed cannabis commission, and the WSLCB’s status.
Board members reviewed feedback from the recent special board meeting and approved a cannabis compact with the Confederated Tribes of the Chehalis Reservation.
As most events were cancelled for the holidays, we encourage stakeholders and policymakers to reflect on how far we’ve come - and verify we’re still heading in the right direction together.
The WSLCB Board and Policy and Rules team heard strong criticisms of the supplemental Quality Control Testing and Product Requirements rule proposal from many stakeholders.
During discussion following her presentation, WSLCB Policy and Rules Manager Kathy Hoffman revealed she was authoring an interpretative statement regarding Delta-8-Tetrahydrocannabinol (Delta-8-THC) which, if implemented, may distill out unanticipated consequences.
In addition to advocacy training, participants learned about future WSLCB rulemaking on advertising, a draft Delta-8-THC policy change, and the Cannabis Regulators Association.